Shanmuga Hospital Ltd

Shanmuga Hospital Ltd has announced the closure of its trading window from July 01, 2026, until 48 hours after the declaration of its Unaudited Financial Results for the quarter ending June 30, 2026 (Q1 FY27). This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. All designated persons, their immediate relatives, and insiders are prohibited from trading in the company's equity shares during this period. The date of the board meeting to approve these financial results will be communicated later.

Dr. Mehak Jamwal, AVP-Operations and Senior Management Personnel at Shanmuga Hospital Ltd, has tendered her resignation due to personal circumstances. Her resignation will be effective from the close of business hours on June 4, 2026. The company has confirmed this change in accordance with SEBI regulations. Dr. Jamwal expressed gratitude for her tenure and pledged support for a smooth transition.

Shanmuga Hospital Ltd has re-appointed M/s J V & Co., Chartered Accountants, Salem, as its Internal Auditors for the financial year 2026-27. The decision was made during the Board of Directors meeting held on May 11, 2026, and complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s J.V.& Co's profile includes details of its partners, office addresses, firm registration number, and audit experience with various banks.

Shanmuga Hospital Ltd. has announced its audited financial results for the half year and year ended March 31, 2026. The Board of Directors approved the results in a meeting held on May 11, 2026. Additionally, the board approved the re-appointment of M/s J V & Co., Chartered Accountants, as the Internal Auditors for the financial year 2026-27. The company will also declare quarterly financial results from FY27 to enhance investor transparency, despite not being mandatory for BSE SME Platform listed companies.

Shanmuga Hospital Ltd's Board of Directors approved the audited financial results for the half-year and year ended March 31, 2026, as recommended by the Audit Committee. The board also approved the re-appointment of M/s J V & Co., Chartered Accountants, Salem, as the Internal Auditors for the financial year 2026-27. Additionally, the company decided to declare and submit quarterly financial results starting from FY27, despite it not being mandatory for BSE SME Platform listed companies, to enhance investor transparency.

Shanmuga Hospital Ltd has scheduled a Board of Directors meeting on May 11, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window is closed from April 1, 2026, until 48 hours after the declaration of the results.

Shanmuga Hospital Ltd, formerly known as Shanmuga Hospital Private Limited, has announced the closure of its trading window for dealing in shares of the company. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulation, 2015, and the company's code of conduct. The trading window will remain closed from April 01, 2026, till 48 hours after the announcement/declaration of Audited Financial Results of the Company for the Year ended 31st March, 2026. All Designated Persons, their immediate relatives, and other Insiders of the Company are advised not to deal in Equity Shares of the Company during the aforesaid period of Closure of Trading Window. The date of the Board Meeting in which the financial results are to be approved will be informed in due course.

Dr Vaishak M.L., the Chief Operations Officer of Shanmuga Hospital Ltd, has tendered his resignation to pursue his growth opportunities outside the organization. He will be relieved from his duties on March 21, 2026, and will cease to be a Senior Management Personnel of the Company. The resignation was announced in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shanmuga Hospital Ltd has announced the appointment of Dr. Mehak Jamwal as the Assistant Vice President - Operations. Dr. Jamwal, a healthcare administration professional with around 10 years of experience, will report directly to the CEO. She has been recognized for her performance in healthcare operations and has a strong background in clinical practices and healthcare management. This is a new position created to enhance healthcare delivery systems, optimize operational workflows, and improve patient service outcomes.

Shanmuga Hospital Limited has announced the commissioning of a Litho Evo Laser Machine at its hospital facility. This addition is in line with the company's continuous efforts to enhance its medical infrastructure and strengthen advanced treatment capabilities, particularly in the area of urology and minimally invasive procedures. The investment, which does not fall under related party transactions, is not expected to have a material impact on the company's financials.